Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK – Get Rating) have been assigned an average rating of “Hold” from the six brokerages that are covering the firm, Marketbeat.com reports. Five research analysts have rated the stock with a hold rating. The average twelve-month price objective among brokerages that have covered the stock in the last year […]
StockNews.com initiated coverage on shares of Anika Therapeutics (NASDAQ:ANIK – Get Rating) in a report issued on Thursday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Several other research firms also recently commented on ANIK. Zacks Investment Research upgraded shares of Anika Therapeutics from a sell rating to a hold rating […]